These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16300833)

  • 1. Infrared fluorescent immunofocus assay (IR-FIFA) for the quantitation of non-cytopathic and minimally cytopathic viruses.
    Counihan NA; Daniel LM; Chojnacki J; Anderson DA
    J Virol Methods; 2006 Apr; 133(1):62-9. PubMed ID: 16300833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of infectious duck hepatitis B virus by radioimmunofocus assay.
    Anderson DA; Grgacic EV; Luscombe CA; Gu X; Dixon R
    J Med Virol; 1997 Aug; 52(4):354-61. PubMed ID: 9260680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of flaviviruses by fluorescent focus assay.
    Payne AF; Binduga-Gajewska I; Kauffman EB; Kramer LD
    J Virol Methods; 2006 Jun; 134(1-2):183-9. PubMed ID: 16510196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemiluminescent focus assays for the quantitation of hepatitis A virus and rotavirus in cell cultures.
    Richards GP; Watson MA
    J Virol Methods; 2001 May; 94(1-2):69-80. PubMed ID: 11337041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In situ enzyme immunoassay for detection of hepatitis A virus].
    Hou Z; Yan J; Long R
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):362-4. PubMed ID: 12759978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ immune infrared fluorescent staining for detection and quantitation of bluetongue virus in Culicoides insect cell culture.
    Mecham JO; Brown PL; McHolland LE
    J Virol Methods; 2009 Jun; 158(1-2):110-3. PubMed ID: 19428578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
    Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
    Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
    Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
    J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    J Med Virol; 1996 May; 49(1):1-6. PubMed ID: 8732864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathic effects and focus formation by reticuloendotheliosis viruses in a quail fibroblast cell line.
    Cho BR
    Avian Dis; 1983; 27(1):261-70. PubMed ID: 6303292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus.
    Sauerbrei A; Schacke M; Glück B; Egerer R; Wutzler P
    J Hosp Infect; 2006 Dec; 64(4):358-65. PubMed ID: 17011665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature and density dependent induction of a cytopathic effect following infection with non-cytopathic HAV strains.
    Wales SQ; Ngo D; Hida K; Kulka M
    Virology; 2012 Aug; 430(1):30-42. PubMed ID: 22608060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
    Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
    J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An indirect immunocolorimetric assay to detect rubella virus infected cells.
    Chen MH; Zhu Z; Zhang Y; Favors S; Xu WB; Featherstone DA; Icenogle JP
    J Virol Methods; 2007 Dec; 146(1-2):414-8. PubMed ID: 17919742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies.
    Beales LP; Wood DJ; Minor PD; Saldanha JA
    J Virol Methods; 1996 May; 59(1-2):147-54. PubMed ID: 8793842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus.
    Kiyohara T; Totsuka A; Yoneyama T; Ishii K; Ito T; Wakita T
    Arch Virol; 2009; 154(8):1263-9. PubMed ID: 19578927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Miller DS; Halpern M; Kotlarski I; Jilbert AR
    Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles virus targets DC-SIGN to enhance dendritic cell infection.
    de Witte L; Abt M; Schneider-Schaulies S; van Kooyk Y; Geijtenbeek TB
    J Virol; 2006 Apr; 80(7):3477-86. PubMed ID: 16537615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of virus using laser-based scanning of near-infrared fluorophores replaces manual plate reading in a virus titration assay.
    Weldon SK; Mischnick SL; Urlacher TM; Ambroz KL
    J Virol Methods; 2010 Sep; 168(1-2):57-62. PubMed ID: 20438762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.